Review
Copyright ©The Author(s) 2017.
World J Hepatol. Jun 28, 2017; 9(18): 797-807
Published online Jun 28, 2017. doi: 10.4254/wjh.v9.i18.797
Table 4 Clinical trials with immunotherapy in hepatocellular carcinoma
AuthorsnPhaseTreatmentPrimary end-point
Keynote-224100IIPembrolizumabRR
ongoingIIPembrolizumabDCR
CheckMate-040I/IINivolumabSafety
CheckMate-459726IIINivolumab vs SorafenibOS
TTP